These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 987161)

  • 21. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of narcotic analgesics with dopamine receptors in rat brain.
    Govoni S; Kumakura K; Spano PF; Tonon GC; Trabucchi M
    Pharmacol Res Commun; 1975 Feb; 07(1):95-100. PubMed ID: 239406
    [No Abstract]   [Full Text] [Related]  

  • 23. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 1991 Sep; 202(2):273-6. PubMed ID: 1839386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of 2-chloro-11-(4-methyl-l-piperazinyl) dibenz(b,f)(1,4)oxazepine (loxapine) and its derivatives on the dopamine-sensitive adenylate cyclase of rat striatal homogenates.
    Coupet J; Szucs VA; Greenblatt EN
    Brain Res; 1976 Oct; 116(1):177-80. PubMed ID: 974768
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
    Miller RJ; Horn AS; Iversen LL
    J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
    [No Abstract]   [Full Text] [Related]  

  • 26. Genotype-dependent sensitivity to morphine: dopamine involvement in morphine-induced running in the mouse.
    Trabucchi M; Spano PF; Racagni G; Oliverio A
    Brain Res; 1976 Sep; 114(3):536-40. PubMed ID: 182326
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 29. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of dopamine on activation of rat striatal adenylate cyclase by free Mg2+ and guanyl nucleotides.
    McSwigan JD; Nicol SE; Gottesman II; Tuason VB; Frey WH
    J Neurochem; 1980 Mar; 34(3):594-601. PubMed ID: 7354334
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of bromocriptine on central dopaminergic receptors.
    Trabucchi M; Spano PF; Tonon GC; Frattola L
    Life Sci; 1976 Jul; 19(2):225-31. PubMed ID: 183071
    [No Abstract]   [Full Text] [Related]  

  • 32. Esters of apomorphine and N,N-dimethyldopamine as agonists of dopamine receptors in the rat brain in vivo.
    Baldessarini RJ; Walton KG; Borgman RJ
    Neuropharmacology; 1975 Oct; 14(10):725-31. PubMed ID: 1238952
    [No Abstract]   [Full Text] [Related]  

  • 33. Denervation supersensitivity in the mesolimbic system: involvement of dopamine-stimulated adenylate cyclase.
    Rosenfeld MR; Seeger TF; Sharpless NS; Gardner EL; Makman MH
    Brain Res; 1979 Sep; 173(3):572-6. PubMed ID: 487111
    [No Abstract]   [Full Text] [Related]  

  • 34. Narcotic dependence, narcotic action and dopamine receptors.
    Lal H
    Life Sci; 1975 Aug; 17(4):483-95. PubMed ID: 171531
    [No Abstract]   [Full Text] [Related]  

  • 35. beta-Adrenergic receptor-sensitive adenosine cyclic 3',5'-monophosphate accumulation in homogenates of the rat corpus striatum. A comparison with the dopamine receptor-coupled adenylate cyclase.
    Harris JE
    Biochem Pharmacol; 1978; 27(24):2919-25. PubMed ID: 216372
    [No Abstract]   [Full Text] [Related]  

  • 36. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 37. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum.
    Schwarcz R; Creese I; Coyle JT; Snyder SH
    Nature; 1978 Feb; 271(5647):766-8. PubMed ID: 625348
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of ergots on adenylate cyclase activity in the corpus striatum and pituitary.
    Schmidt MJ; Hill LE
    Life Sci; 1977 Mar; 20(5):789-97. PubMed ID: 15714761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.